Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.42 |
| ▸ | NPY1R | P25929 | 7/20 | 0.42 |
| ▸ | NPY2R | P49146 | 5/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30484000 | 0.98 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30111320 | 0.94 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL9614927 | 0.92 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL27732271 | 0.92 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL15011349 | 0.92 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29619336 | 0.91 | CPB2 (0.45) | NPY4RNPY1RNPY2RNPY5RFOLH1 | |
| SCHEMBL30855541 | 0.89 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL6038374 | 0.89 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30303032 | 0.89 | ENPEP (0.46) | ENPEP | |
| SCHEMBL31277463 | 0.89 | ENPEP (0.46) | ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11993640-B2 | Treating inflammatory lung disease | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2024-05-28 | — | — | US | disclosed |